BIOA
BioAge Labs (BIOA)
$72
About BioAge Labs (BIOA)
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.
Details
Daily high
$11.94
Daily low
$11.23
Price at open
$11.40
52 Week High
$25.96
52 Week Low
$4.25
Market cap
501.0M
Dividend yield
0.00%
Volume
19,969
Avg. volume
1.3M
P/E ratio
-4.72
BioAge Labs News
Details
Daily high
$11.94
Daily low
$11.23
Price at open
$11.40
52 Week High
$25.96
52 Week Low
$4.25
Market cap
501.0M
Dividend yield
0.00%
Volume
19,969
Avg. volume
1.3M
P/E ratio
-4.72